The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
Open accessAbstract
Translocations in hematologic disease of myeloid or lymphoid origin with breakpoints at chromosome band 12p13 frequently result in rearrangements of the Ets variant gene 6 (ETV6). As a consequence either the ETS DNA-binding domain or the Helix-Loop-Helix (HLH) oligomerization domain of ETV6 is fused to different partner genes. We show here that a t(9; 12)(p24; p13) in a case of early pre-B acute lymphoid leukemia and a t(9; 15; 12)(p24; q15; p13) in atypical chronic myelogenous leukemia in transformation involve the ETV6 gene at 12p13 and the JAK2 gene at 9p24. In each case different fusion mRNAs were found, with only one resulting in an open reading frame for a chimeric protein consisting of the HLH oligomerization domain of ETV6 and the protein tyrosine kinase (PTK) domain of JAK2. The cloning of the complete human JAK2 coding and genomic sequences and of the genomic junction fragments of the translocations allowed a characterization of the different splice events leading to the various mRNAs. JAK2 plays a central role in non–protein tyrosine kinase receptor signaling pathways, which could explain its involvement in malignancies of different hematologic lineages. Besides hop in Drosophila no member of the JAK family has yet been implicated in tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Ihle, J. N. (1995) · Nature · doi:10.1038/377591a0 · Cited by 1,203
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Shurtleff, S. A., Buijs, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G., Pui, C., Grosveld, G. C., & Downing, J. R. (1995) · PubMed · Cited by 547
The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Cleveland, J. L., Yi, T., & Ihle, J. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8429 · Cited by 501
Harrison, D. A., Binari, R., Nahreini, T. S., Gilman, M., & Perrimon, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07285.x · Cited by 469
High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
Romana, S., Poirel, H., Leconiat, M., Flexor, M., Mauchauffe, M., Jonveaux, P., Macintyre, E., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v86.11.4263.bloodjournal86114263 · Cited by 427
Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., & Hirai, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06288.x · Cited by 325
Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia
Golub, T. R., Goga, A., Barker, G. F., Afar, D. E. H., McLaughlin, J., Bohlander, S. K., Rowley, J. D., Witte, O. N., & Gilliland, D. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4107 · Cited by 324
Current status of cytogenetic research in childhood acute lymphoblastic leukemia
Raimondi, S. (1993) · Blood · doi:10.1182/blood.v81.9.2237.2237 · Cited by 295
Carroll, M., Tomasson, M. H., Barker, G. F., Golub, T. R., & Gilliland, D. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14845 · Cited by 268
The novel activation of ABL by fusion to an ets-related gene, TEL.
Papadopoulos, P., Ridge, S. A., Boucher, C. A., Stocking, C., & Wiedemann, L. M. (1995) · PubMed · Cited by 256
Raynaud, S., Cave, H., Baens, M., Bastard, C., Cacheux, V, Grosgeorge, J., Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P., et al. (1996) · Blood · doi:10.1182/blood.v87.7.2891.bloodjournal8772891 · Cited by 242
Self-citationBuijs, A., Sherr, S. E., van Baal, S., van Bezouw, S., van der Plas, D. C., van Kessel, A. H. M. G., Riegman, P. H. J., Deprez, R. H. L., Zwarthoff, E. C., & Hagemeijer, A. (1995) · PubMed · Cited by 225
Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
Chilcote, R. R., Brown, E., & Rowley, J. D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508013130503 · Cited by 150
Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders.
Peeters, P. J., Włodarska, I., Baens, M., Criel, A. M., Selleslag, D., Hagemeijer, A., BERGHE, H. V. D., & Marynen, P. (1997) · PubMed · Cited by 125
Self-citationA possible subgroup of ALL with 9p−
Kowalczyk, J., & Sandberg, A. A. (1983) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(83)90086-9 · Cited by 120
Raimondi, S., Williams, D., Callihan, T., Peiper, S., Rivera, G. K., & Murphy, S. (1986) · Blood · doi:10.1182/blood.v68.1.69.69 · Cited by 115
Genomic organization of TEL: the human ETS-variant gene 6.
Baens, M., Peeters, P. J., Guo, C., Aerssens, J., & Marynen, P. (1996) · Genome Research · doi:10.1101/gr.6.5.404 · Cited by 113
Self-citationXu, X., Kang, S. H., Heidenreich, O. T., Okerholm, M., O’Shea, J. J., & Nerenberg, M. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118193 · Cited by 112
Włodarska, I., Mecucci, C., Marynen, P., Guo, C., Franckx, D., Starza, R. L., Aventin, A. M., Bosly, A., Martelli, M., & Cassiman, J. (1995) · Blood · doi:10.1182/blood.v85.10.2848.bloodjournal85102848 · Cited by 100
Self-citationNakamura, N., Chin, H., Miyasaka, N., & Miura, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19483 · Cited by 82
Cayuela, J., Baruchel, A., Orange, C., Madani, A., Auclerc, M.-F., Daniel, M., Schaison, G., & Sigaux, F. (1996) · Blood · doi:10.1182/blood.v88.1.302.302 · Cited by 82
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.
Xia, K., Mukhopadhyay, N. K., Inhorn, R. C., Barber, D. L., Rose, P., Lee, R. S., Narsimhan, R. P., D’Andrea, A. D., Griffin, J. D., & Roberts, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11681 · Cited by 79
Two members of the JAK family of protein tyrosine kinases map to Chromosomes 1p31.3 and 9p24
Pritchard, M. A., Baker, E. G., Callen, D. F., Sutherland, G. R., & Wilks, A. F. (1992) · Mammalian Genome · doi:10.1007/bf00355839 · Cited by 41
Signal Transduction by a CD16/CD7/Jak2 Fusion Protein
Sakai, I., Nabell, L. M., & Kraft, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18420 · Cited by 34
Wilks, A. F., & Oates, A. C. (1996) · PubMed · Cited by 29
Cited by
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Self-citationCools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
Self-citationWidespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
Jones, A. V. (2005) · Blood · doi:10.1182/blood-2005-03-1320 · Cited by 843
Metadata
- Authors
- Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H., & Marynen, P.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-10-01
- Volume
- 90
- Issue
- 7
- Pages
- 2535-2540
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2303212700
- Cited by
- 491
- References
- 32
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.